The development of effective anticoagulant therapies has revolutionized the treatment and prevention of cardiovascular diseases, a leading cause of mortality worldwide. Central to the synthesis of these life-saving medications are specialized chemical intermediates, meticulously engineered to facilitate complex molecular assembly. One such critical compound is CAS 211915-84-3, a high-purity pharmaceutical intermediate that serves as a cornerstone in the production of modern anticoagulants.

CAS 211915-84-3, chemically identified as Ethyl 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid, is a complex benzimidazole derivative. Its molecular formula is C27H26N6O3, with a molecular weight of 482.53. Typically appearing as a white crystalline powder, its well-defined physical and chemical properties make it an ideal building block for sophisticated pharmaceutical synthesis. The compound's intricate structure is precisely designed to integrate into larger molecular frameworks, ultimately forming the active pharmaceutical ingredient (API) of various drugs.

The primary and most significant application of CAS 211915-84-3 is its role as a key intermediate in the synthesis of Dabigatran etexilate. Dabigatran etexilate is a direct thrombin inhibitor and a prodrug that is converted to Dabigatran, an active anticoagulant. This class of drugs offers significant advantages in managing conditions such as non-valvular atrial fibrillation, reducing the risk of stroke and systemic embolism. The availability of high-quality CAS 211915-84-3 from reliable manufacturers is therefore directly linked to the consistent production of this essential medication.

For researchers and formulators, understanding the chemical characteristics of this intermediate is crucial. Its purity, often specified at 99% or higher, ensures that downstream synthetic steps proceed efficiently and with minimal impurities. When you buy CAS 211915-84-3, you are securing a precisely manufactured component that contributes to the overall efficacy and safety of the final drug product. We, as a dedicated manufacturer and supplier, prioritize these quality aspects, ensuring that our offerings meet the stringent demands of the pharmaceutical industry.

The synthesis of complex molecules like Dabigatran etexilate is a multi-step process. Intermediates such as CAS 211915-84-3 are products of advanced organic chemistry, developed to simplify and optimize the overall manufacturing route. By sourcing this compound, pharmaceutical companies can enhance their production efficiency, reduce costs, and ensure a stable supply of critical medications to patients who need them. We encourage all potential buyers to request a quote and sample to experience the quality and reliability we offer for this essential pharmaceutical intermediate.

In summary, CAS 211915-84-3 represents more than just a chemical compound; it is a vital link in the chain of pharmaceutical innovation, particularly in the field of anticoagulation. Its precise chemical structure and high purity are indispensable for the synthesis of Dabigatran etexilate, underscoring the importance of reliable suppliers and manufacturers in ensuring global access to essential medicines.